JP2007517016A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007517016A5 JP2007517016A5 JP2006546397A JP2006546397A JP2007517016A5 JP 2007517016 A5 JP2007517016 A5 JP 2007517016A5 JP 2006546397 A JP2006546397 A JP 2006546397A JP 2006546397 A JP2006546397 A JP 2006546397A JP 2007517016 A5 JP2007517016 A5 JP 2007517016A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- solid composition
- composition according
- particles
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 claims 26
- 229940079593 drug Drugs 0.000 claims 25
- 239000008247 solid mixture Substances 0.000 claims 15
- 239000002245 particle Substances 0.000 claims 13
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 6
- 229960000502 poloxamer Drugs 0.000 claims 6
- 229920001983 poloxamer Polymers 0.000 claims 6
- 230000009477 glass transition Effects 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 1
- 229940081735 acetylcellulose Drugs 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 125000005591 trimellitate group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53383603P | 2003-12-31 | 2003-12-31 | |
| PCT/IB2004/004287 WO2005065657A2 (en) | 2003-12-31 | 2004-12-20 | Solid compositions of low-solubility drugs and poloxamers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007517016A JP2007517016A (ja) | 2007-06-28 |
| JP2007517016A5 true JP2007517016A5 (cg-RX-API-DMAC7.html) | 2008-02-14 |
Family
ID=34748969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006546397A Abandoned JP2007517016A (ja) | 2003-12-31 | 2004-12-20 | 低溶解性薬剤及びポロキサマーの固体組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8974823B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1701704A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007517016A (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0418330A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2548376A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005065657A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005047561A1 (de) * | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| EP2142178B1 (en) * | 2007-03-29 | 2012-01-11 | F. Hoffmann-La Roche AG | Pharmaceutical composition and process |
| HRP20191104T1 (hr) | 2007-09-25 | 2019-09-20 | Solubest Ltd. | Pripravci koji sadrže lipofilne aktivne spojeve i postupak za njihovu pripremu |
| US8889193B2 (en) | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
| SMT202000390T1 (it) * | 2010-07-12 | 2020-09-10 | Salix Pharmaceuticals Inc | Formulazioni di rifaximina e loro usi |
| US20170087134A1 (en) * | 2010-07-12 | 2017-03-30 | Salix Pharmaceuticals, Ltd | Formulations of rifaximin and uses thereof |
| WO2012039979A2 (en) | 2010-09-10 | 2012-03-29 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
| EP2455068A1 (en) * | 2010-11-09 | 2012-05-23 | F. Hoffmann-La Roche AG | Pharmaceutical composition for treating HCV infections |
| JP2014532658A (ja) * | 2011-10-28 | 2014-12-08 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | ブルトン型チロシンキナーゼ疾患または障害を治療する方法 |
| US8962577B2 (en) | 2012-03-16 | 2015-02-24 | The Johns Hopkins University | Controlled release formulations for the delivery of HIF-1 inhibitors |
| CA2867203C (en) | 2012-03-16 | 2016-09-20 | The Johns Hopkins University | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
| WO2013166408A1 (en) | 2012-05-03 | 2013-11-07 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
| CN111700878A (zh) * | 2012-05-03 | 2020-09-25 | 卡拉制药公司 | 显示提高的粘膜转移的药物纳米粒子 |
| US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| US9056057B2 (en) | 2012-05-03 | 2015-06-16 | Kala Pharmaceuticals, Inc. | Nanocrystals, compositions, and methods that aid particle transport in mucus |
| US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
| CA2872519C (en) | 2012-05-04 | 2017-09-05 | The Johns Hopkins University | Lipid-based drug carriers for rapid penetration through mucus linings |
| US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
| CN105188371A (zh) | 2013-02-08 | 2015-12-23 | 西建阿维拉米斯研究公司 | Erk抑制剂及其用途 |
| JP5946798B2 (ja) * | 2013-06-18 | 2016-07-06 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| JP5934677B2 (ja) * | 2013-06-18 | 2016-06-15 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
| JP6010060B2 (ja) * | 2014-02-21 | 2016-10-19 | 住友ゴム工業株式会社 | タイヤ用ゴム組成物、及び空気入りタイヤ |
| WO2016025561A1 (en) | 2014-08-13 | 2016-02-18 | Celgene Avilomics Research, Inc. | Forms and compositions of an erk inhibitor |
| RU2639819C2 (ru) * | 2014-12-30 | 2017-12-22 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Композиция, ингибирующая теломеразу |
| JP6846351B2 (ja) | 2015-01-27 | 2021-03-24 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤 |
| CA3038312A1 (en) | 2016-09-30 | 2018-04-05 | Salix Pharmaceuticals, Inc. | Solid dispersion forms of rifaximin |
| WO2020210805A1 (en) | 2019-04-11 | 2020-10-15 | The Johns Hopkins University | Nanoparticles for drug delivery to brain |
| CA3184054A1 (en) | 2020-06-26 | 2021-12-30 | Jacob Cole | Targeted release rifaximin compositions |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE80467B1 (en) | 1995-07-03 | 1998-07-29 | Elan Corp Plc | Controlled release formulations for poorly soluble drugs |
| DK0996429T3 (da) | 1997-10-27 | 2003-05-26 | Merck Patent Gmbh | Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler |
| AU4797999A (en) | 1998-07-22 | 2000-02-14 | Yamanouchi Pharmaceutical Co., Ltd. | Solid preparation containing sparingly soluble nsaids |
| US6368622B2 (en) | 1999-01-29 | 2002-04-09 | Abbott Laboratories | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| EP1175205B1 (en) | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| WO2001034118A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Solid dispersion pharmaceutical formulations |
| JP2004500358A (ja) | 1999-12-08 | 2004-01-08 | ファルマシア コーポレイション | バイオアベイラビリティーが増加した固体状態のセレコキシブ |
| YU43702A (sh) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka |
| KR100806412B1 (ko) | 2000-01-28 | 2008-02-21 | 스미스클라인 비참 코포레이션 | 전기방사 약제학적 조성물 |
| AR028253A1 (es) * | 2000-03-16 | 2003-04-30 | Pfizer Prod Inc | Inhibidores de la glucogeno fosforilasa |
| PE20011184A1 (es) * | 2000-03-16 | 2001-11-15 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa |
| US20010036959A1 (en) | 2000-04-03 | 2001-11-01 | Gabel Rolf Dieter | Carvedilol-hydrophilic solutions |
| AU2001257115B2 (en) | 2000-04-20 | 2005-01-27 | Rtp Pharma Inc. | Improved water-insoluble drug particle process |
| US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| GB0015239D0 (en) | 2000-06-21 | 2000-08-16 | Biochemie Gmbh | Organic compounds |
| DE10038571A1 (de) | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
| KR20020014570A (ko) | 2000-08-18 | 2002-02-25 | 김충섭 | 고체분산화시킨 무정형 이프리플라본의 제조방법 |
| CZ20033211A3 (cs) * | 2001-05-03 | 2004-09-15 | F. Hoffmann-La Roche Ag | Farmaceutická léková forma amorfního nelfinavir mesylátu |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| PL372247A1 (en) * | 2002-02-01 | 2005-07-11 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| AU2003214387A1 (en) * | 2002-03-07 | 2003-09-16 | Biocompatibles Uk Limited | Drug carriers comprising amphiphilic block copolymers |
-
2004
- 2004-12-20 EP EP04806454A patent/EP1701704A2/en not_active Withdrawn
- 2004-12-20 US US10/596,876 patent/US8974823B2/en not_active Expired - Fee Related
- 2004-12-20 BR BRPI0418330-4A patent/BRPI0418330A/pt not_active IP Right Cessation
- 2004-12-20 CA CA002548376A patent/CA2548376A1/en not_active Abandoned
- 2004-12-20 JP JP2006546397A patent/JP2007517016A/ja not_active Abandoned
- 2004-12-20 WO PCT/IB2004/004287 patent/WO2005065657A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2005324132B2 (en) | Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release | |
| Khan et al. | Formulation, characterisation and stabilisation of buccal films for paediatric drug delivery of omeprazole | |
| ES2351947T3 (es) | Formulaciones orales de liberacion controlada de un inhibidor de la enzima convertidora de interleucina-1-beta. | |
| JP2011516612A5 (cg-RX-API-DMAC7.html) | ||
| MXPA02001243A (es) | Medios para crear una masa que tiene integridad estructural. | |
| JP2009502487A5 (cg-RX-API-DMAC7.html) | ||
| KR102663478B1 (ko) | 에다라본 약제학적 조성물 | |
| JP6364406B2 (ja) | 口腔内崩壊錠 | |
| DE60313359D1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| JP2013525394A (ja) | 経口投与剤形 | |
| CN103550158B (zh) | 一种大黄素固体分散体、含药丸芯和结肠靶向微丸及其用途 | |
| CN102548543B (zh) | 具有改进的溶出率和最小的副作用的缓释的西洛他唑片剂 | |
| JP6838446B2 (ja) | トルバプタン製剤およびその製造方法 | |
| CN100463674C (zh) | 一种氯雷他定口腔速溶膜及其制备方法 | |
| Pinto et al. | Cellulose ethers for extrusion applications | |
| WO2025108447A1 (zh) | 一种吲哚布芬缓释制剂及其制备方法和应用 | |
| CN107072954B (zh) | 用于口服给药的包含洛贝格列酮的药物组合物 | |
| JP2002512946A5 (cg-RX-API-DMAC7.html) | ||
| CN110946835A (zh) | 一种利伐沙班固体分散片及其制备方法 | |
| BR112014026040B1 (pt) | Comprimido de liberação sustentada que contém levodropropizina | |
| CN103505421B (zh) | 一种盐酸度洛西汀的肠溶微丸制剂 | |
| CN104013582B (zh) | 一种阿司匹林peg-plga微球的制备方法 | |
| JP6072705B2 (ja) | 固体分散体製剤 | |
| CN104971052A (zh) | 含有非马沙坦钾三水合物的药物组合物及其制备方法 | |
| CN102805738B (zh) | 盐酸普罗帕酮缓释制剂及制备方法 |